Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Low-grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00880581
What this trial is testing

Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphomas: Non-Hodgkin Follicular / Indolent B-Cell+1 more
Ronald Levy 30
Testing effectiveness (Phase 2)UnknownNCT00041730
What this trial is testing

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Favrille 90
Testing effectiveness (Phase 2)Study completedNCT00002510
What this trial is testing

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Not applicableUnknownNCT05284825
What this trial is testing

A Phase II Trial of Intermediate Radiation Dose For Lymphoma

Who this might be right for
Follicular Lymphoma
Sunnybrook Health Sciences Centre 27
Not applicableNot Yet RecruitingNCT07210749
What this trial is testing

Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma

Who this might be right for
Orbital Lymphoma
British Columbia Cancer Agency 36
Not applicableUnknownNCT00022958
What this trial is testing

Expanded Access Study of Iodine-131 Anti-B1 Antibody

Who this might be right for
Non-Hodgkin's Lymphoma
Corixa Corporation
Testing effectiveness (Phase 2)Ended earlyNCT00012298
What this trial is testing

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more
National Cancer Institute (NCI) 81
Testing effectiveness (Phase 2)Study completedNCT00006241
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00115700
What this trial is testing

Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Trans Tasman Radiation Oncology Group 150
Testing effectiveness (Phase 2)Ended earlyNCT02701517
What this trial is testing

Cyclosporine Plus Methotrexate or Alemtuzumab

Who this might be right for
Unrecognized Condition: Mature B or T-cell Neoplasm
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 72
Not applicableStudy completedNCT03323450
What this trial is testing

Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory

Who this might be right for
GliomaBrain Tumor, Primary
Virginia Commonwealth University 20
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00240578
What this trial is testing

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 88
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00143845
What this trial is testing

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Who this might be right for
Multiple MyelomaLymphocytic Leukemia, ChronicLymphoma, Low-Grade
University of Michigan Rogel Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT00377195
What this trial is testing

Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma

Who this might be right for
Non-gastric Marginal Zone Lymphoma
Trans Tasman Radiation Oncology Group 79
Testing effectiveness (Phase 2)Study completedNCT00253630
What this trial is testing

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT02266147
What this trial is testing

Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Dynavax Technologies Corporation 29
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Study completedNCT00002779
What this trial is testing

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 34
Next Page